scholarly journals Breed-dependent microRNA expression in the primary culture of skeletal muscle cells subjected to myogenic differentiation

BMC Genomics ◽  
2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Tomasz Sadkowski ◽  
Anna Ciecierska ◽  
Jolanta Oprządek ◽  
Edyta Balcerek
2013 ◽  
Vol 304 (2) ◽  
pp. C128-C136 ◽  
Author(s):  
Miriam Hoene ◽  
Heike Runge ◽  
Hans Ulrich Häring ◽  
Erwin D. Schleicher ◽  
Cora Weigert

Myogenic differentiation of skeletal muscle cells is characterized by a sequence of events that include activation of signal transducer and activator of transcription 3 (STAT3) and enhanced expression of its target gene Socs3. Autocrine effects of IL-6 may contribute to the activation of the STAT3-Socs3 cascade and thus to myogenic differentiation. The importance of IL-6 and STAT3 for the differentiation process was studied in C2C12 cells and in primary mouse wild-type and IL-6−/− skeletal muscle cells. In differentiating C2C12 myoblasts, the upregulation of IL-6 mRNA expression and protein secretion started after increased phosphorylation of STAT3 on tyrosine 705 and increased mRNA expression of Socs3 was observed. Knockdown of STAT3 and IL-6 mRNA in differentiating C2C12 myoblasts impaired the expression of the myogenic markers myogenin and MyHC IIb and subsequently myotube fusion. However, the knockdown of IL-6 did not prevent the induction of STAT3 tyrosine phosphorylation. The IL-6-independent activation of STAT3 was verified in differentiating primary IL-6−/− myoblasts. The phosphorylation of STAT3 and the expression levels of STAT3, Socs3, and myogenin during differentiation were comparable in the primary myoblasts independent of the genotype. However, IL-6−/− cells failed to induce MyHC IIb expression to the same level as in wild-type cells and showed reduced myotube formation. Supplementation of IL-6 could partially restore the fusion of IL-6−/− cells. These data demonstrate that IL-6 depletion during myogenic differentiation does not reduce the activation of the STAT3-Socs3 cascade, while IL-6 and STAT3 are both necessary to promote myotube fusion.


2006 ◽  
Vol 294 (1-2) ◽  
pp. 163-171 ◽  
Author(s):  
Jaskirat Singh ◽  
Navin Kumar Verma ◽  
Sejal M. Kansagra ◽  
Bhusan N. Kate ◽  
Chinmoy Sankar Dey

2011 ◽  
Vol 317 (3) ◽  
pp. 356-366 ◽  
Author(s):  
Ai Shima ◽  
Jennifer Pham ◽  
Erica Blanco ◽  
Elisabeth R. Barton ◽  
H. Lee Sweeney ◽  
...  

2008 ◽  
Vol 1783 (5) ◽  
pp. 813-825 ◽  
Author(s):  
Nina Hanke ◽  
Joachim D. Meissner ◽  
Renate J. Scheibe ◽  
Volker Endeward ◽  
Gerolf Gros ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
Yusaku Kodaka ◽  
Gemachu Rabu ◽  
Atsushi Asakura

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the potential to differentiate into various types of cells including skeletal muscle cells. The approach of converting ESCs/iPSCs into skeletal muscle cells offers hope for patients afflicted with the skeletal muscle diseases such as the Duchenne muscular dystrophy (DMD). Patient-derived iPSCs are an especially ideal cell source to obtain an unlimited number of myogenic cells that escape immune rejection after engraftment. Currently, there are several approaches to induce differentiation of ESCs and iPSCs to skeletal muscle. A key to the generation of skeletal muscle cells from ESCs/iPSCs is the mimicking of embryonic mesodermal induction followed by myogenic induction. Thus, current approaches of skeletal muscle cell induction of ESCs/iPSCs utilize techniques including overexpression of myogenic transcription factors such as MyoD or Pax3, using small molecules to induce mesodermal cells followed by myogenic progenitor cells, and utilizing epigenetic myogenic memory existing in muscle cell-derived iPSCs. This review summarizes the current methods used in myogenic differentiation and highlights areas of recent improvement.


Sign in / Sign up

Export Citation Format

Share Document